Patients with moderate to severe type 1 diabetes showed improvements in fasting C-peptide levels and significant reductions in HbA1C rates and insulin doses 12 and 24 weeks after treatment with cord blood stem cells, researchers reported in BMC Medicine.
Stem cell treatment shows efficacy in type 1 diabetes
SmartBrief Job Listings for Health Care
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||